Cancer incidence among musicians: 45 years of follow-up in four Nordic countries

Figures & data

Table 1. Observed and expected numbers of cancers and standardized incidence ratios (SIR) with 95% confidence intervals (CI) among 11,401 male musicians in Finland, Iceland, Norway, and Sweden, follow-up 1961–2005, for cancer sites with at least 5 expected cases.

ICD-7	Site	Observed	Expected	SIR	95% CI
140–204	All sites	1663	1633.59	1.02	0.97	1.11
145–148	Pharynx	32	11.82	2.71	1.85	3.82
145	Oropharynx	22	5.04	4.36	2.73	6.60
150	Oesophagus	43	20.64	2.08	1.51	2.81
155.0	Liver	35	19.32	1.81	1.26	2.52
141	Tongue	12	6.75	1.78	0.92	3.11
178	Testis	17	10.62	1.60	0.93	2.56
	Seminoma	12	7.48	1.60	0.83	2.80
190	Skin melanoma	77	55.14	1.40	1.10	1.75
161	Larynx	24	18.38	1.31	0.84	1.94
143–144	Oral cavity	11	8.58	1.28	0.64	2.29
201	Hodgkin lymphoma	11	8.60	1.28	0.64	2.29
152	Small intestine	9	7.59	1.19	0.54	2.25
157	Pancreas	60	50.96	1.18	0.90	1.52
153	Colon	130	111.85	1.16	0.97	1.38
181	Bladder	124	109.87	1.13	0.94	1.35
154	Rectum, rectosigma	85	78.08	1.09	0.87	1.35
204	Leukemia	40	39.08	1.02	0.73	1.39
	Acute myeloid	6	10.52	0.57	0.21	1.24
177	Prostate	414	407.18	1.02	0.92	1.12
180	Kidney	61	60.56	1.01	0.77	1.29
194	Thyroid	9	9.05	0.99	0.45	1.89
197	Soft tissue	10	10.67	0.94	0.45	1.72
199	Other/unknown site	44	46.99	0.94	0.68	1.26
180.1	Renal pelvis	5	5.50	0.91	0.30	2.12
191	Skin, squamous cell	57	64.72	0.88	0.67	1.14
193	Brain	41	47.68	0.86	0.62	1.17
	Glioma	19	23.87	0.80	0.48	1.24
200,202	Non-Hodgkin lymphoma	43	52.60	0.82	0.59	1.10
162,163	Lung	161	209.35	0.77	0.65	0.90
	Adenocarcinoma	33	37.34	0.88	0.61	1.24
	Small cell	29	29.14	1.00	0.67	1.43
	Squamous cell	46	67.45	0.68	0.50	0.91
	Other	52	71.43	0.73	0.54	0.95
203	Multiple myeloma	18	24.18	0.74	0.44	1.18
155.1	Gallbladder	6	8.83	0.68	0.25	1.48
151	Stomach	57	85.74	0.66	0.50	0.86
179.0	Penis	3	5.01	0.60	0.12	1.75
158, 162.2	Mesothelioma	2	6.79	0.29	0.04	1.06
140	Lip	2	14.99	0.13	0.02	0.48

Shown in the order of the SIR of the main site.

Table 2. Observed and expected numbers of cancers and standardized incidence ratios (SIR) with 95% confidence intervals (CI) among 3105 female musicians in Finland, Iceland, Norway and Sweden, follow-up 1961–2005, for cancer sites with at least 5 expected cases.

ICD-7	Site	Observed	Expected	SIR	95% CI
140–204	All sites	376	360.8	1.04	0.94	1.15
191	Skin, squamous cell	16	9.96	1.61	0.92	2.61
200,202	Non-Hodgkin lymphoma	13	9.48	1.37	0.73	2.34
175.0	Ovary	26	20.11	1.29	0.84	1.89
172	Corpus uteri	26	20.14	1.29	0.84	1.89
157	Pancreas	12	9.81	1.22	0.63	2.14
181	Bladder	9	7.69	1.17	0.53	2.22
170	Breast	128	109.70	1.17	0.97	1.39
151	Stomach	13	11.53	1.13	0.60	1.93
153	Colon	26	27.20	0.96	0.62	1.40
194	Thyroid	6	6.46	0.93	0.34	2.02
193	Brain	12	12.99	0.92	0.48	1.61
154	Rectum, rectosigma	12	13.47	0.89	0.46	1.56
162,163	Lung	15	17.74	0.85	0.47	1.40
190	Skin melanoma	11	13.25	0.83	0.41	1.48
171	Cervix uteri	9	11.71	0.77	0.35	1.46
204	Leukemia	3	6.41	0.47	0.10	1.37
180	Kidney	3	8.29	0.36	0.07	1.06

Table 3. Country-specific numbers (N) of selected cancers and standardized incidence ratios (SIR) with 95% confidence intervals (CI) among male musicians in Finland, Norway, and Sweden, follow-up 1961–2005.

Site	Finland				Norway				Sweden
	N	SIR	95% CI		N	SIR	95% CI		N	SIR	95% CI
All sites	422	0.92	0.84	1.15	346	1.05	0.98	1.16	874	1.05	0.98	1.06
Pharynx	6	2.31	0.85	5.02	8	3.60	1.55	7.09	18	2.60	1.54	4.11
Oropharynx	2	1.78	0.22	6.44	5	5.76	1.87	13.45	15	4.94	2.77	8.15
Oesophagus	6	1.04	0.38	2.26	8	2.14	0.92	4.21	29	2.67	1.79	3.84
Liver	12	1.87	0.96	3.26	1	0.46	0.01	2.58	22	2.07	1.30	3.14
Testis	7	3.33	1.34	6.86	3	1.34	0.28	3.93	7	1.15	0.46	2.36
Skin melanoma	15	1.07	0.60	1.77	17	1.54	0.90	2.46	43	1.44	1.04	1.95
Larynx	7	1.15	0.46	2.36	6	1.54	0.56	3.35	11	1.34	0.67	2.40
Oral cavity	7	3.29	1.32	6.79	2	1.04	0.13	3.77	2	0.45	0.05	1.62
Prostate	102	0.96	0.78	1.16	65	0.90	0.69	1.15	242	1.08	0.94	1.22
Skin, squamous cell	11	0.88	0.44	1.57	14	0.96	0.53	1.62	32	0.86	0.59	1.21
Lung	44	0.50	0.37	0.67	35	0.84	0.59	1.18	80	1.01	0.80	1.16
Stomach	16	0.64	0.36	1.03	17	0.81	0.47	1.30	22	0.56	0.35	0.85
Lip	0	0	0	0.68	0	0	0	1.13	2	0.13	0.04	1.15

Results for Iceland not shown because of small numbers of cases.

Table 4. Numbers (N) of selected cancers and standardized incidence ratios (SIR) with 95% confidence intervals (CI) among male musicians in Finland, Iceland, Norway, and Sweden, by period of follow-up.

Site	1961–1975				1976–1990				1991–2005
	N	SIR	95% CI		N	SIR	95% CI		N	SIR	95% CI
All sites	182	1.08	0.93	1.25	559	1.05	0.97	1.15	922	0.98	0.92	1.05
Pharynx	4	2.56	0.70	6.54	7	1.87	0.75	3.86	21	3.22	1.99	4.93
Oropharynx	3	8.09	1.67	23.63	5	3.91	1.27	9.13	14	4.12	2.25	6.92
Oesophagus	7	3.02	1.22	6.22	16	2.39	1.36	3.88	20	1.72	1.05	2.66
Liver	7	3.59	1.44	7.40	15	2.16	1.21	3.57	13	1.25	0.66	2.13
Testis	3	1.60	0.33	4.69	7	1.96	0.79	4.04	7	1.35	0.54	2.78
Skin melanoma	9	2.11	0.96	4.01	27	1.60	1.05	2.33	41	1.21	0.86	1.64
Larynx	7	2.35	0.95	4.89	11	1.54	0.77	2.75	6	0.75	0.26	1.58
Oral cavity	0	0	0	3.80	4	1.38	0.38	3.52	7	1.49	0.60	3.07
Prostate	23	1.04	0.66	1.56	103	1.01	0.83	1.23	288	1.02	0.90	1.14
Skin, squamous cell	3	0.85	0.18	2.49	22	1.29	0.81	1.96	32	0.72	0.49	1.02
Lung	20	0.77	0.47	1.18	64	0.78	0.60	0.99	77	0.76	0.60	0.95
Stomach	9	0.52	0.24	0.98	27	0.77	0.51	1.12	21	0.63	0.39	0.96
Lip	0	0	0	1.22	0	0	0	0.58	2	0.36	0.04	1.29

Table 5. Numbers (N) of selected cancers and standardized incidence ratios (SIR) with 95% confidence intervals (CI) among male musicians in Finland, Iceland, Norway, and Sweden, by age at follow-up.

Site	30–49 years				50–69 years				70+ years
	N	SIR	95% CI		N	SIR	95% CI		N	SIR	95% CI
All sites	153	1.08	0.92	1.27	773	0.98	0.92	1.06	737	1.04	0.96	1.11
Pharynx	5	2.62	0.85	6.12	22	2.98	1.86	4.50	5	1.98	0.64	4.63
Oropharynx	2	2.06	0.25	7.44	16	5.01	2.86	8.13	4	4.55	1.24	11.65
Oesophagus	4	3.19	0.87	8.18	21	1.82	1.12	2.78	18	2.30	1.36	3.63
Liver	2	1.56	0.19	5.64	15	1.62	0.90	2.56	18	2.06	1.22	3.25
Testis	14	1.85	1.01	3.10	3	1.15	0.24	3.36	0	0	0	8.45
Skin melanoma	17	1.16	0.68	1.86	37	1.37	0.96	1.88	23	1.71	1.08	2.57
Larynx	5	2.73	0.89	6.37	13	1.14	0.61	1.95	6	1.16	0.43	2.53
Oral cavity	2	1.66	0.20	6.01	8	1.60	0.69	3.14	1	0.42	0.01	2.36
Prostate	4	1.32	0.36	3.39	169	0.97	0.83	1.13	241	1.05	0.92	1.19
Skin, squamous cell	4	1.22	0.33	3.13	11	0.55	0.27	0.98	42	1.02	0.73	1.37
Lung	5	0.41	0.13	0.95	88	0.73	0.59	0.90	68	0.88	0.69	1.12
Stomach	8	1.08	0.47	2.13	27	0.63	0.42	0.92	22	0.62	0.39	0.94
Lip	0	0	0	2.60	0	0	0	0.47	2	0.35	0.04	1.27